Bluestar Adisseo Company provided unaudited earnings guidance for the year 2017. For the year, the net profit contributed to shareholders is expected to be RMB 1.32 billion, better than the company’s original budget of RMB 1.16 billion. The 2017 revenue is expected to be RMB 10.4 billion, a minor decrease of 2.7% compared with last year. But despite the decreasing methionine price in 2017, the company’s revenue remains flat because of a high sales volume growth of methionine by 11% on average, of which liquid methionine’s growth rate is even higher, versus a global methionine demand growing by 6% already.